Effects of GLP-1 Receptor Agonists on Hair Loss and Regrowth: A Systematic Review

    Miranda K. Branyiczky, Megan S. Lowe, Eric McMullen, Jeffrey Donovan, Touraj Khosravi‐Hafshejani
    Image of study
    TLDR GLP-1 receptor agonists may cause hair loss, but regrowth is rare.
    This systematic review investigates the effects of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on hair loss and regrowth, analyzing 10 studies with a total of 920,890 adverse events and 382 patients in cohort studies. The review found a weak association between GLP-1RA use and hair loss, particularly with semaglutide and tirzepatide, but also noted cases of hair regrowth. Hair loss was reported in 1.6% of 626,894 patients, while hair regrowth was rare (0.008%). Mechanisms potentially linking GLP-1RA therapy to hair outcomes include hormonal changes, rapid weight loss, and nutritional deficiencies. The study highlights the need for larger cohort studies to better understand the relationship between GLP-1RAs and hair disorders, as causality cannot be inferred from the current data.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    2 / 2 results

      community Gyno & testoterone level

      in Finasteride  282 upvotes 1 year ago
      Switching from finasteride to dutasteride and back to finasteride led to gynecomastia and fatigue, likely due to hormonal imbalances. Suggested treatments include Tamoxifen, Raloxifene, or low-dose Anastrozole, with a recommendation to test testosterone and estradiol levels.

    Similar Research

    5 / 257 results